0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Urology & urogenital medicine

Buy Now

Oral Pharmacotherapy for Male Sexual Dysfunction - A Guide to Clinical Management (Paperback, Softcover reprint of hardcover 1st ed. 2005) Loot Price: R4,031
Discovery Miles 40 310
Oral Pharmacotherapy for Male Sexual Dysfunction - A Guide to Clinical Management (Paperback, Softcover reprint of hardcover...

Oral Pharmacotherapy for Male Sexual Dysfunction - A Guide to Clinical Management (Paperback, Softcover reprint of hardcover 1st ed. 2005)

Gregory A Broderick

Series: Current Clinical Urology

 (sign in to rate)
Loot Price R4,031 Discovery Miles 40 310 | Repayment Terms: R378 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

For the generation that reached sexual maturity in the 1960s, the "pill" became synonymous with sexual freedom and started a sexual revolution. For women it meant freedom from the fear of pregnancy, and for men enhanced sexual opportunity. The new era of the pill has nothing to do with fertility, but everything to do with sex. The first orally effective prescr- tion drug for treating erectile dysfunction (ED) was marketed in 1998. (R) Sildenafil (Viagra ) has rejuvenated the aging male veterans of the sexual revolution, forever changed the science of sexual medicine, and tra- formed society's perspective on aging and sex. This class of drugs, known as oral phosphodiesterase inhibitors (PDE-type 5), is highly effective in the treatment of ED. Since its introduction there has been a much greater awa- ness of ED, its comorbidities, and its effects on the quality of life. In 1997, while preparing to address the Endocrine Society on the occasion of the 92nd American Urological Association meeting, I first looked at the p- clinical studies of sildenafil. I thought "this will change everything" and it clearly has-changing practice patterns in sexual medicine, and the at- tudes of patients, potential patients, and their partners. Two new PDE-type (R) (R) 5 inhibitors, tadalafil (Cialis ) and vardenafil (Levitra ), were first approved by the European Committee for Proprietary Medicinal Products and subsequently by the Food and Drug Administration in 2003 and 2004.

General

Imprint: HumanaPress
Country of origin: United States
Series: Current Clinical Urology
Release date: December 2010
First published: 2005
Editors: Gregory A Broderick
Dimensions: 229 x 152 x 26mm (L x W x T)
Format: Paperback
Pages: 464
Edition: Softcover reprint of hardcover 1st ed. 2005
ISBN-13: 978-1-61737-578-1
Categories: Books > Medicine > Clinical & internal medicine > Urology & urogenital medicine
LSN: 1-61737-578-0
Barcode: 9781617375781

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners